Fairooz Kabbinavar - 30 Jan 2023 Form 3 Insider Report for Cardiff Oncology, Inc. (CRDF)

Role
Chief Medical Officer
Signature
/s/ Fairooz Kabbinavar
Issuer symbol
CRDF
Transactions as of
30 Jan 2023
Net transactions value
$0
Form type
3
Filing time
09 Feb 2023, 15:50:59 UTC
Next filing
07 Mar 2024
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding CRDF Stock Options 30 Jan 2023 Common Stock 425,000 $1.75 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 25% of the shares subject to the option will vest on January 30, 2024 and the remaining shares vest in 36 equal monthly installments thereafter, subject to Dr. Kabbinavar's continued service.